The Lancet

[Articles] Causes of and risk factors for postpartum ha...

The finding that uterine atony is the commonest cause of postpartum haemorrhage ...

[Comment] The promise and compromise of the WHO Pandemi...

As scientists, health professionals, and lawyers engaged in reducing pandemic sp...

[Comment] Protecting global sexual and reproductive hea...

The actions of the US Government are causing serious harm to sexual and reproduc...

[Comment] Mobilising national and regional assets and n...

The global health landscape stands at a critical inflection point. Multilateral ...

[Comment] Weighing up causes of and risk factors for po...

Reducing the maternal mortality rate due to postpartum haemorrhage depends on th...

[Articles] SAPIEN 3 versus Myval transcatheter heart va...

Myval THVs were non-inferior to SAPIEN 3 THVs in terms of a 1-year composite end...

[Comment] Head-to-head comparison of balloon-expandable...

Transcatheter aortic valve intervention (TAVI) is a well established therapy for...

[Comment] Hospitals as tenants: the rise of real estate...

As financial actors including private equity funds increasingly buy and sell hos...

[Comment] From coronary artery disease to atherosclerot...

Atherosclerosis starts early in life, progresses with age, with lesions distribu...

[The Lancet Commissions] The Lancet Commission on rethi...

Coronary artery disease has long been understood through the paradigm of epicard...

[Editorial] Rethinking coronary artery disease: a call ...

For decades, the clinical approach to coronary artery disease has been centred o...

[Articles] Durability and efficacy of solbinsiran, a Ga...

Solbinsiran 400 mg reduced apoB in patients with mixed dyslipidaemia and was gen...

[Comment] Therapy for mixed dyslipidaemia through ANGPT...

In epidemiological, genetic, and intervention studies, mixed dyslipidaemia, char...

[Articles] Efficacy and safety of clopidogrel versus as...

Among patients who were at high risk of recurrent ischaemic events and who compl...

[Articles] Outcomes after fractional flow reserve-guide...

At the 5-year follow-up, there was no significant difference in a composite outc...

[Comment] Clopidogrel use in chronic coronary syndrome:...

Low-dose aspirin is the traditional drug of choice in patients with chronic coro...

[Comment] Fractional flow reserve-guided percutaneous c...

Early studies showed that coronary artery bypass grafting (CABG) was superior to...

[Articles] Angiography-derived fractional flow reserve ...

The angiography-derived FFR-guided comprehensive PCI strategy, encompassing reva...

[Comment] Achieve more with less metal in PCI: angiogra...

A decade after the first introduction of angiography-derived fractional flow res...

[Articles] Orbital atherectomy versus balloon angioplas...

Routine treatment with orbital atherectomy before drug-eluting stent implantatio...

[Comment] Orbital atherectomy for severely calcified co...

Severely calcified coronary artery lesions are encountered increasingly frequent...

[Comment] Increasing walking capacity in patients with ...

The treatment of many patients with peripheral artery disease is not optimal, an...

[Articles] Semaglutide and walking capacity in people w...

Semaglutide increased walking distance in patients with symptomatic peripheral a...

[Articles] Effect of invitation to colonoscopy versus f...

Participation in screening was higher among individuals invited to faecal immuno...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.